UCB U.S. News | UCB

UCB's Global Corporate Website

Welcome to UCB in the United States

Healthcare Professionals

Categories

Archives

2026
- June
- May
- April
- March
- February
2025
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
2024
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
2023
- December
- November
- October
- September
- August
- July
- June
- April
- March
- February
- January
2022
- December
- November
- September
- August
- June
- May
- March
- February
- January
2021
- December
- November
- October
- September
- August
- May
- April
- February

May

19

BIMZELX® (bimekizumab-bkzx) demonstrates superior efficacy over SKYRIZI® (risankizumab-rzaa) in psoriatic arthritis: BE BOLD Week 16 data

Read More

May

14

UCB Issues Voluntary Recall of Select Lots of CIMZIA® Pre-Filled Syringes (PFS) in the United States

Read More

May

04

UCB to acquire Candid Therapeutics, building upon its existing immunology pipeline with novel T-cell engagers

Read More

Choose a Country